Provided by Tiger Trade Technology Pte. Ltd.

IMPACT THERAP-B

14.070
+0.1401.01%
Volume:9.63M
Turnover:138.60M
Market Cap:3.97B
PE:-10.87
High:15.110
Open:14.100
Low:13.700
Close:13.930
52wk High:47.980
52wk Low:10.310
Shares:282.46M
HK Float Shares:282.46M
Volume Ratio:1.42
T/O Rate:3.41%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.295
ROE:--
ROA:-40.35%
PB:4.38
PE(LYR):-10.87
PS:28.75

Loading ...

Movement Alert|IMPACT THERAP-B Rises 8.26% in Regular Trading, Senaparib European CHMP Approval Catalyst Continues to Drive Gains

Market Focus
·
Sep 29

Movement Alert|IMPACT THERAP-B Falls 8.05% in Regular Trading, Profit-Taking After Recent Surge Compounded by Biotech Sector Weakness

Market Focus
·
Sep 24

Hong Kong Equities Close Higher | Hang Seng Index Regains 25,000 Mark, Innovative Drug Shares Rally Broadly, SBP Group Tops Blue-Chip Gainers

Stock News
·
Sep 21

IMPACT THERAP-B Soars Over 37% as Its Drug Nears EU Approval

Deep News
·
Sep 21

Housing Market Enters Inventory Era; MiniMax Open-Sources Code CLI - Key Overnight Developments

Stock News
·
Sep 21

Major Milestone Achieved: European Regulators Endorse Sepalna as Impact Therapeutics-B (07630) Surges 15.51% at Close

Stock News
·
Sep 18

Impact Therapeutics Gets Positive EMA Opinion for Ovarian Cancer Drug

MT Newswires Live
·
Sep 18

Impact Therapeutics - Senaparib Submitted to European Commission for Final Marketing Authorization Decision

THOMSON REUTERS
·
Sep 18

Impact Therapeutics and Pharmanovia Announce Positive Chmp Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

THOMSON REUTERS
·
Sep 18

Morning Market Recap: Hong Kong Stocks Edge Higher, AI Drug Development Sector Surges

Stock News
·
Sep 18

IMPACT THERAP-B Surges Over 20% in Morning Trading Following Stock Connect Inclusion and Insider Buying

Deep News
·
Sep 18

IMPACT Therapeutics Delivers 317% Revenue Surge and Narrows Interim Loss on Robust Senaparib Sales and IPO Proceeds

Bulletin Express
·
Sep 14

IMPACT THERAP-B Shares Added to Shanghai-Shenzhen Stock Connect Programs

Stock News
·
Sep 07

IMPACT Therapeutics Added to Both Shanghai- and Shenzhen-Hong Kong Stock Connect Lists

Bulletin Express
·
Sep 07

Impact Therapeutics Added to Shanghai, Shenzhen Stock Connect Eligible List from Sept. 7, 2026

Reuters
·
Sep 07

IMPACT THERAP-B Joins Stock Connect, Opening Doors for Mainland Investors

Stock News
·
Sep 04

Insider Purchase: Cai Suixiong Boosts Stake in Impact Therapeutics with HK$1.46 Million Deal

Stock News
·
Sep 03

IMPACT THERAP-B: Sui Xiong Cai Acquires Shares, Long Position Rises to 6.56%

HK Disclosure
·
Sep 03

Hong Kong Stocks Fall on Thursday, Amid Bond Selloff, Rate Fears; HUTCHMED Jumps 14%

MT Newswires Live
·
Sep 03

Hong Kong Stock Market Update: IMPACT THERAP-B (07630) Surges Nearly 13% on Core Drug Growth and Index Inclusion Prospects

Stock News
·
Sep 03